Bladder Cancer Protein GSDMB Boosts Immunotherapy by Recruiting Immune Cells
A new study reveals that the protein GSDMB enhances anti-PD-1 immunotherapy in bladder cancer by driving Sema7a-mediated recruitment and activation ...
A new study reveals that the protein GSDMB enhances anti-PD-1 immunotherapy in bladder cancer by driving Sema7a-mediated recruitment and activation ...
New research shows that activated platelets bind CD8-positive T cells via P-selectin and PSGL-1, directly suppressing their tumor-killing activity and ...
A new review argues that the ketogenic diet may act as a systems-level sensitization platform in cancer therapy by simultaneously ...
Xiamen University researchers report that inhibiting RNASET2, a magnesium-sensitive enzyme that clears mitochondrial double-stranded RNA, ignites innate immune signaling in ...
Pancreatic cancer has long been regarded as one of the most difficult cancers to treat, not only because malignant cells ...
In a groundbreaking study published recently, researchers have unveiled the intricate and powerful interplay between ferroptosis and immunotherapy in the ...
In the unrelenting battle against pancreatic cancer, a malignancy notorious for its dismal prognosis and resistance to conventional therapies, a ...
In recent years, the landscape of cancer treatment has been dramatically transformed by the advent of immune checkpoint inhibitors (ICIs), ...
In the ever-evolving field of cancer research, recent studies have unveiled critical insights into the mechanisms underlying immunotherapy resistance, particularly ...
High levels of fat mass and obesity-associated protein, commonly known as FTO, are increasingly recognized for their role in promoting ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine